 |
|
|
| |
Injection-Site Reaction Experience in Clinical Studies of People Using Lenacapavir For HIV Treatment
|
| |
| |
AIDS 2022, 29 July-2 August, Montreal, Quebec, Canada
Princy Kumar,1 Samir Gupta,2 Sorana Segal-Maurer,3 Onyema Ogbuagu,4 Cheryl McDonald,5 Cynthia Brinson,6
Anne Chester,7 Hui Wang,7 Hadas Dvory-Sobol,7 Martin S. Rhee,7 Jared M. Baeten,7 Jean-Michel Molina8
1Georgetown University Medical Center, Washington, DC, USA; 2Indiana University, Indianapolis, Indiana, USA; 3New York Presbyterian-Queens, Flushing, New York, USA; 4Yale University, New Haven, Connecticut, USA; 5Texas Centers for Infectious Disease Associates, Fort Worth, Texas, USA; 6Central Texas Clinical Research, Austin, Texas; 7Gilead Sciences, Inc., Foster City, California, USA; 8Hopital Saint-Louis, Paris, France
|
| |
|
|
|
|
|
